Patents by Inventor Bart Burington

Bart Burington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
    Patent number: 9951389
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: April 24, 2018
    Assignee: Geron Corporation
    Inventors: Ekaterina Bassett, Bart Burington, Hui Wang, Kevin Eng
  • Methods for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
    Patent number: 9617600
    Abstract: The invention provides methods and kits useful for predicting or assessing responsiveness of a patient having B-cell lymphoma to treatment with anti-CD40 antibodies.
    Type: Grant
    Filed: April 17, 2010
    Date of Patent: April 11, 2017
    Assignee: Genentech, Inc.
    Inventors: David Dornan, Bart Burington
  • DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
    Publication number: 20160177403
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Application
    Filed: October 30, 2015
    Publication date: June 23, 2016
    Inventors: Ekaterina BASSETT, Bart BURINGTON, Hui WANG, Kevin ENG
  • DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
    Publication number: 20150344963
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds. The methods comprise identifying individuals who will benefit from said treatment based on the average relative length of telomeres in cancer cells from said individuals.
    Type: Application
    Filed: November 27, 2013
    Publication date: December 3, 2015
    Inventors: Ekaterina BASSETT, Bart BURINGTON, Hui WANG, Kevin ENG
  • Diagnostic markers for treating cell proliferative disorders with telomerase inhibitors
    Patent number: 9200327
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: December 1, 2015
    Assignee: Geron Corporation
    Inventors: Ekaterina Bassett, Bart Burington, Hui Wang, Kevin Eng
  • Methods and compositions for assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies
    Patent number: 9068230
    Abstract: The invention provides methods and kits useful for predicting or assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: June 30, 2015
    Assignee: Genentech, Inc.
    Inventors: David Dornan, Bart Burington
  • DIAGNOSTIC MARKERS FOR TREATING CELL PROLIFERATIVE DISORDERS WITH TELOMERASE INHIBITORS
    Publication number: 20140155465
    Abstract: Provided herein are methods for identifying individuals diagnosed with a cell proliferative disorder that will benefit from treatment with a telomerase inhibitor compound. Also provided herein are methods for treating these individuals with telomerase inhibitor compounds.
    Type: Application
    Filed: March 13, 2013
    Publication date: June 5, 2014
    Inventors: Ekaterina BASSETT, Bart Burington, Hui Wang, Kevin Eng
  • METHODS FOR ASSESSING RESPONSIVENESS OF B-CELL LYMPHOMA TO TREATMENT WITH ANTI-CD40 ANTIBODIES
    Publication number: 20120123695
    Abstract: The invention provides methods and kits useful for predicting or assessing responsiveness of a patient having B-cell lymphoma to treatment with anti-CD40 antibodies.
    Type: Application
    Filed: April 17, 2010
    Publication date: May 17, 2012
    Inventors: David Dornan, Bart Burington
  • METHODS AND COMPOSITIONS FOR ASSESSING RESPONSIVENESS OF B-CELL LYMPHOMA TO TREATMENT WITH ANTI-CD40 ANTIBODIES
    Publication number: 20110104671
    Abstract: The invention provides methods and kits useful for predicting or assessing responsiveness of B-cell lymphoma to treatment with anti-CD40 antibodies.
    Type: Application
    Filed: November 7, 2008
    Publication date: May 5, 2011
    Inventors: David Dornan, Bart Burington